Contributors: Joanna Boag-Thomson
Date published: 1 May 2013
A smattering of recent relevant patent law developments
This webinar, which was run on 30 April, provides an overview of some recent patent cases and changes to the relevant patent law regimes that are of particular interest to the life sciences sector. Topics covered include the unitary patent, the unified patents court agreement, Neurim Pharmaceuticals v Comptroller-General of Patents, Actavis v Eli Lilly, Novartis v Generics, Brustle v Greenpeace, the extension of the UK Bolar research exception and some other highlights.
A smattering of recent relevant patent law developments
Contributors:
Joanna Boag-Thomson
Partner
Further / related posts
28 October 2025
Contributors:
Louisa Knox, Hamish Patrick, Donald Smith, Peter Alderdice
17 October 2025
Lift off from Shetland after Skyrora secures vertical launch licence
Contributor: Ruairidh Leishman
31 July 2024
The Court of Appeal’s decision on the patentability of computer-implemented AI inventions.
Contributor: Ruairidh Leishman
To find out more contact us here
Sectors: Pharma, Biotech, Medtech, and Digital Health, Technology and Life Sciences
